Stay Alert for Patients Taking a New, Injectable Migraine Prophylaxis Med

August 2018

You may see some home med lists contain erenumab (Aimovig, AIM-oh-vig), a new subcutaneous biologic to PREVENT migraine in adults.

It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.

Expect other "CGRP antagonists" to be approved within a few months.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Nephrology Look for Factors Affecting Dosing During Continuous Renal Replacement Therapy
Liver Disease Treat Most Spontaneous Bacterial Peritonitis With 5 Days of Antibiotics
Nutrition Consider Smoflipid as an Alternative to Traditional IV Lipids
Opioids Clarify Opioid Reactions as Adverse Effects or True Allergies
Heart Failure Assess Med Options When Standard Heart Failure Therapy Isn't Enough
New Drugs Avoid Mix-Ups With the Newest Insulin Glargine Pen, Toujeo Max SoloStar
Neurology & Pain Weigh the Pros and Cons of Perioperative Gabapentin or Pregabalin
Anticoagulants Lean Toward Apixaban When a DOAC Is Desired for Atrial Fibrillation
New Drugs Stay Alert for Patients Taking a New, Injectable Migraine Prophylaxis Med